Cite
Endocrine treatment options for advanced breast cancer--the role of fulvestrant
MLA
Jwr W. R. Nortier, et al. Endocrine Treatment Options for Advanced Breast Cancer--the Role of Fulvestrant. Jan. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b24f10fd0244e0161f7113e01cdb2ad0&authtype=sso&custid=ns315887.
APA
Jwr W. R. Nortier, Se E. Jones, Se E. Come, Jfr F. R. Robertson, Manfred Kaufmann, Louk V.A.M. Beex, Andreas Makris, Le-E. Rutqvist, & Kurt Possinger. (2005). Endocrine treatment options for advanced breast cancer--the role of fulvestrant.
Chicago
Jwr W. R. Nortier, Se E. Jones, Se E. Come, Jfr F. R. Robertson, Manfred Kaufmann, Louk V.A.M. Beex, Andreas Makris, Le-E. Rutqvist, and Kurt Possinger. 2005. “Endocrine Treatment Options for Advanced Breast Cancer--the Role of Fulvestrant,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b24f10fd0244e0161f7113e01cdb2ad0&authtype=sso&custid=ns315887.